Skip to main content

Advertisement

SpringerLink
Log in

Predictors Associated with the Willingness to Take Human Papilloma Virus Vaccination

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Human papilloma virus vaccine is considered to be the primary form of cervical cancer prevention. The objectives were (1) to determine knowledge about, and perception of human papilloma virus infection in relation to cervical cancer, (2) to explore the intention of the community to be vaccinated with human papilloma virus vaccine, and (3) to identify variables that could predict the likelihood of uptake of the vaccine. A cross-sectional survey was carried out in a semi-urban Town of Malaysia, using a pre-tested structured questionnaire. Summary statistics, Pearson chi-square test and a binary logistic regression were used for data analysis. A total of 232 respondents were interviewed. Overall, only a few had good knowledge related to human papilloma virus (14%) or vaccination (8%). Many had misconceptions that it could be transmitted through blood transfusion (57%). Sixty percent had intention to take vaccination. In the binary logistic model, willingness to take vaccination was significant with ‘trusts that vaccination would be effective for prevention of cervical cancer’ (P = 0.001), ‘worries for themselves’ (P < 0.001) or ‘their family members’ (P = 0.003) and ‘being Indian ethnicity’ (P = 0.024). The model could fairly predict the likelihood of uptake of the vaccine (Cox & Snell R 2 = .415; Nagelkerke R 2 = 0.561). Results indicate that intensive health education dispelling misconception and risk perception towards human papilloma virus infection and cervical cancer would be helpful to increase the acceptability of vaccination program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Munoz, N. (2000). Human papilloma virus and cancer: The epidemiological evidence. Journal of Clinical Virology, 19(1–2), 1–5.

    Article  PubMed  CAS  Google Scholar 

  2. Andersson, S., Rylander, E., Larsson, B., Strand, A., Silfversvard, C., & Wilander, E. (2001). The role of human papilloma virus in cervical adenocarcinoma carcinogenesis. European Journal of Cancer, 37, 246–250.

    Article  PubMed  CAS  Google Scholar 

  3. Tabora, N., Bakkers, M. J. E., Quint, W. G. V., et al. (2009). Human papilloma virus infection in Honduran women with normal cytology. Cancer Causes and Control, 20(9), 1663–1670.

    Article  PubMed  CAS  Google Scholar 

  4. Barr, E., & Tamms, G. (2007). Quadrivalent human papilloma virus vaccine. Clinical Infectious Diseases, 45(5), 609–617.

    Article  PubMed  Google Scholar 

  5. International Agency for Research on Cancer (IARC). (2010). Joint international union against cancer-cervical cancer action. World cancer day—4th February 2010. http://www.iarc.fr/en/media-centre/pr/2010/pdfs/pr199E.pdf.

  6. Lim, G. C. C., & Halimah, Y. (2004). The second report of the national cancer registry. Cancer incidence in Malaysia 2003. Ministry of Health Malaysia: National Cancer Registry.

    Google Scholar 

  7. Wong, L. P., & Sam, I. C. (2007). Current issues facing the introduction of human papilloma virus in Malaysia. Malaysian Family Physician, 2(2), 1985–2274.

    Google Scholar 

  8. Mohd Rushdan Md Noor. (2008). Current status and future direction of cervical cancer prevention program in Malaysia. From http://site.obgynanrush.com/clients/obgynanrush/Downloads/Cervical_Cancer_Prevention_in_Malaysia_by_Rushdan_for_OGSM_web11202008122411PM.pdf.

  9. World Health Organization (WHO). (2003). Global cancer rates could increase by 50% to 15 million by 2020. From http://www.who.int/mediacentre/news/releases/2003/pr27/en/.

  10. Armstrong, E. P. (2010). Prophylaxis of cervical cancer and related cervical disease: A review of the cost-effectiveness of vaccination against oncogenic HPV types. Journal of Managed Care Pharmacy, 16(3), 217–230.

    PubMed  Google Scholar 

  11. Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory informed, systematic review. Preventive Medicine, 45, 107–114.

    Article  PubMed  Google Scholar 

  12. Markowitz, L. E., Hariri, S., Unger, E. R., Saraiya, M., Datta, S. D., & Dunne, E. F. (2010). Post-licensure monitoring of HPV vaccine in the United States. Vaccine, 28, 4731–4737.

    Article  PubMed  Google Scholar 

  13. Rosenstock, I. M., Strecher, V. J., & Becker, M. H. (1988). Social learning theory and the health belief model. Health Education Quarterly, 15, 175–183.

    Article  PubMed  CAS  Google Scholar 

  14. Mortensen, G. L. (2010). Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: A qualitative and quantitative study. BMC Public Health, 14(10), 68.

    Article  Google Scholar 

  15. Al-Naggar, R. A., Al-Jashamy, K., & Chen, R. (2010). Perceptions and opinions regarding human papilloma virus vaccination among young women in Malaysia. Asian Pacific Journal of Cancer Prevention, 11, 1515–1521.

    PubMed  Google Scholar 

  16. Wong, L. P. (2010). Role of men in promoting the uptake of HPV vaccinations: Focus groups’ finding from a developing country. International Journal of Public Health, 55, 35–42.

    Article  PubMed  Google Scholar 

  17. Field, A. (2005). Interpreting logistic regression. Discovering Statistics Using SPSS (pp 233–268). London: SAGE Publications.

    Google Scholar 

  18. Reis, C., Heisler, M., Amowitz, L. L. et al. (2005). Discriminatory attitudes and practices by health workers toward patients with HIV/AIDS in Nigeria. PLoS Med 2(8): e246. doi:10.1371/journal.pmed.0020246.

  19. Ogilvie, G. S., Remple, V. P., Marra, F., et al. (2007). Parental intention to have daughters receive the human papilloma virus vaccine. Canadian Medical Association Journal, 177, 1506–1512.

    Article  PubMed  Google Scholar 

  20. Zimet, G. D., Maysm, R. M., Winston, Y., Kee, R., Dickes, J., & Su, L. (2000). Acceptability of human papilloma virus immunization. Journal of Women’s Health Gender Based Medicine, 9, 47–50.

    Article  PubMed  CAS  Google Scholar 

  21. Walsh, C. D., Gera, A., Shah, M., Sharma, A., Powell, J. E., & Wilson, S. (2008). Public knowledge and attitudes towards human papilloma virus (HPV) vaccination. BMC Public Health, 8, 368.

    Article  PubMed  Google Scholar 

  22. Al-Nuaimi, N. S., Al-Ghas, Y. S., Al-Owais, A. H., et al. (2011). Human papilloma virus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates. International Journal of STD and AIDS, 22, 400–404. doi:10.1258/ijsa.2009.009380.

    Article  PubMed  CAS  Google Scholar 

  23. Reiter, P. L., Brewer, N. T., Gottlieb, S. L., McRee, A.-L., & Smith, J. S. (2009). Parents’ health beliefs and HPV vaccination of their adolescent daughters. Social Science and Medicine, 69, 475–480.

    Article  PubMed  Google Scholar 

  24. Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, C., Patel, S., et al. (2007). Prevalence of HPV infection among females in the United States. Journal of American Association, 297, 813–819.

    Article  CAS  Google Scholar 

  25. Centers for Disease Control and Prevention (CDC). (2010). Cervical cancer. From http://www.cdc.gov/cancer/cervical/pdf/Cervical_FS_0510.pdf.

  26. Lu, J. T. F., Cai, Y., Tsui, H. Y., & Choi, K. C. (2010). Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong. Vaccine, 28, 5389–5397.

    Article  Google Scholar 

  27. Naing, C., & Tan, R. Y. P. (2011). Knowledge about the pandemic influenza A (H1N1) and willingness to accept vaccination: A cross-sectional survey. Journal of Public Health, doi:10.1007/s10389-011-0434-2.

Download references

Acknowledgments

The authors are very grateful to the International Medical University (IMU), Malaysia for allowing us to perform this study; the participants in this study for their time and cooperation; the medical director and staff of the Nilai clinic for their support and facilitation in data collection; the students of IMU (ME 1/09, the Nilai group) for helping with data collection; Professor Hematram Yadav for his technical advice; and Prof Yeoh Peng Nam for her inputs in discussion. The opinions expressed in this article are those of the authors and do not represent any institution.

Author information

Authors and Affiliations

  1. School of Medical Sciences, International Medical University (IMU), 57000, Kuala Lumpur, Malaysia

    Cho Naing, Joanne Pereira, Tatsuki Abe, Daniel Eh Zhen Wei, Ibrizah Binti Abdul Rahman Bajera & Undugodage Heshan Kavinda Perera

Authors
  1. Cho Naing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanne Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tatsuki Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Eh Zhen Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ibrizah Binti Abdul Rahman Bajera
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Undugodage Heshan Kavinda Perera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cho Naing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naing, C., Pereira, J., Abe, T. et al. Predictors Associated with the Willingness to Take Human Papilloma Virus Vaccination. J Community Health 37, 288–293 (2012). https://doi.org/10.1007/s10900-011-9473-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-011-9473-4

Keywords

Search

Navigation